Business Description
Quest Laboratories Ltd
ISIN : INE0TNW01017
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | 1.67 | |||||
Interest Coverage | 8.68 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.7 | |||||
9-Day RSI | 46.21 | |||||
14-Day RSI | 45.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.42 | |||||
Quick Ratio | 1.03 | |||||
Days Inventory | 275.39 | |||||
Days Sales Outstanding | 548.95 | |||||
Days Payable | 717.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33 | |||||
Operating Margin % | 12.42 | |||||
Net Margin % | 7.1 | |||||
FCF Margin % | 2.68 | |||||
ROE % | 7.17 | |||||
ROA % | 2.58 | |||||
ROIC % | 6 | |||||
ROC (Joel Greenblatt) % | 11.95 | |||||
ROCE % | 11.25 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 142.32 | |||||
PE Ratio without NRI | 142.32 | |||||
PS Ratio | 10.1 | |||||
PB Ratio | 8.11 | |||||
Price-to-Tangible-Book | 7.92 | |||||
Price-to-Free-Cash-Flow | 377.29 | |||||
Price-to-Operating-Cash-Flow | 58.57 | |||||
EV-to-EBIT | 80.12 | |||||
EV-to-EBITDA | 76.96 | |||||
EV-to-Revenue | 10.08 | |||||
EV-to-FCF | 374.81 | |||||
Price-to-Graham-Number | 7 | |||||
Price-to-Net-Current-Asset-Value | 20.35 | |||||
Earnings Yield (Greenblatt) % | 1.24 | |||||
FCF Yield % | 0.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Quest Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 210.627 | ||
EPS (TTM) (₹) | 0.912 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 45.67 | ||
14-Day ATR (₹) | 5.833043 | ||
20-Day SMA (₹) | 129.8675 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (₹) | 102 - 196.8 | ||
Shares Outstanding (Mil) | 16.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Quest Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Quest Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Quest Laboratories Ltd Frequently Asked Questions
What is Quest Laboratories Ltd(NSE:QUESTLAB)'s stock price today?
When is next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB)?
Does Quest Laboratories Ltd(NSE:QUESTLAB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |